Fig. 3From: Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancerDistributions of Recurrence Score® results and percentage Ki-67 positivity among all samples with N1 status confirmed (n = 298 using weighting). IQR, interquartile range; max, maximum; min, minimum; n, sample size; N1, 1–3 positive lymph nodesBack to article page